Glaxosmithkline | Zobowiązania



Current Liabilities Zmiana Data
AbbVie USD 36.4B 2.35B 2025-03
Amgen USD 20.48B 2.53B 2025-06
AstraZeneca USD 33.54B 4.41B 2025-06
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bausch Health Companies USD 4.98B 719M 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 144.66M 1.6M 2025-06
Drreddys Laboratories INR 131.95B 2.65B 2024-12
Eli Lilly USD 39.02B 8.95B 2025-06
GlaxoSmithKline GBP 20.38B 453M 2025-06
Glaxosmithkline GBP 21.7B 238M 2024-12
J&J USD 56.9B 6.58B 2025-03
Merck USD 26.04B 863M 2025-06
Novartis USD 31.71B 95M 2025-06
Pacira USD 313.16M 1.57M 2025-06
Perrigo USD 1.13B 52.3M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Prestige Brands USD 109.67M 3.04M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 29.06B 3.16B 2025-06
Supernus Pharmaceuticals USD 286.36M 4.59M 2025-06
Takeda JPY 2.17T 336.94B 2025-06
Teva Pharmaceutical Industries USD 11.86B 704M 2025-06
Zoetis USD 3.37B 19M 2025-06


Glaxosmithkline Zobowiązania - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.